Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Identification of insertions in PTEN and TP53 in anaplastic thyroid carcinoma with angiogenic brain metastasis.

× No keyword cloud information.

17 in total

1. BRAF V600E inhibition in anaplastic thyroid cancer.

Authors: Michael H Rosove; Parvin F Peddi; John A Glaspy
Journal: N Engl J Med Date: 2013-02-14 Impact factor: 91.245

2. Association of TERT promoter mutation 1,295,228 C>T with BRAF V600E mutation, older patient age, and distant metastasis in anaplastic thyroid cancer.

Authors: Xiaoguang Shi; Rengyun Liu; Shen Qu; Guangwu Zhu; Justin Bishop; Xiaoli Liu; Hui Sun; Zhongyan Shan; Enhua Wang; Yahong Luo; Xianghong Yang; Jiajun Zhao; Jianling Du; Adel K El-Naggar; Weiping Teng; Mingzhao Xing
Journal: J Clin Endocrinol Metab Date: 2015-01-13 Impact factor: 5.958

Review 3. BRAF(V600E) and microenvironment in thyroid cancer: a functional link to drive cancer progression.

Authors: Carmelo Nucera; Jack Lawler; Sareh Parangi
Journal: Cancer Res Date: 2011-03-29 Impact factor: 12.701

4. Late intervention with anti-BRAF(V600E) therapy induces tumor regression in an orthotopic mouse model of human anaplastic thyroid cancer.

Authors: Matthew A Nehs; Carmelo Nucera; Sushruta S Nagarkatti; Peter M Sadow; Dieter Morales-Garcia; Richard A Hodin; Sareh Parangi
Journal: Endocrinology Date: 2011-12-27 Impact factor: 4.736

5. Sites of metastases of anaplastic thyroid carcinoma: autopsy findings in 45 cases from a single institution.

Authors: Nikola Besic; Barbara Gazic
Journal: Thyroid Date: 2013-05-28 Impact factor: 6.568

6. Thyroidectomy with neoadjuvant PLX4720 extends survival and decreases tumor burden in an orthotopic mouse model of anaplastic thyroid cancer.

Authors: Matthew A Nehs; Sushruta Nagarkatti; Carmelo Nucera; Richard A Hodin; Sareh Parangi
Journal: Surgery Date: 2010-12 Impact factor: 3.982

7. Integrated genomic characterization of papillary thyroid carcinoma.

Authors:
Journal: Cell Date: 2014-10-23 Impact factor: 41.582

8. Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers.

Authors: Zhi Liu; Peng Hou; Meiju Ji; Haixia Guan; Kimberly Studeman; Kirk Jensen; Vasily Vasko; Adel K El-Naggar; Mingzhao Xing
Journal: J Clin Endocrinol Metab Date: 2008-05-20 Impact factor: 5.958

9. Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1.

Authors: Julio C Ricarte-Filho; Mabel Ryder; Dhananjay A Chitale; Michael Rivera; Adriana Heguy; Marc Ladanyi; Manickam Janakiraman; David Solit; Jeffrey A Knauf; R Michael Tuttle; Ronald A Ghossein; James A Fagin
Journal: Cancer Res Date: 2009-06-01 Impact factor: 12.701

10. FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.

Authors: Carmelo Nucera; Jerome Eeckhoute; Stephen Finn; Jason S Carroll; Azra H Ligon; Carmen Priolo; Guido Fadda; Mary Toner; Orla Sheils; Marco Attard; Alfredo Pontecorvi; Vânia Nose; Massimo Loda; Myles Brown
Journal: Clin Cancer Res Date: 2009-05-26 Impact factor: 12.531

2 in total

Review 1. Coding Molecular Determinants of Thyroid Cancer Development and Progression.

Authors: Veronica Valvo; Carmelo Nucera
Journal: Endocrinol Metab Clin North Am Date: 2018-12-23 Impact factor: 4.741

2. Thyroid cancer harboring PTEN and TP53 mutations: A peculiar molecular and clinical case report.

Authors: Carla Colombo; Gabriele Pogliaghi; Delfina Tosi; Marina Muzza; Gaetano Bulfamante; Luca Persani; Laura Fugazzola; Valentina Cirello
Journal: Front Oncol Date: 2022-09-02 Impact factor: 5.738

2 in total